Reducing In-Hospital and 60-Day Mortality in ICU Patients After Surgery With Strict Nutritional Supplementation

Sponsor
Seoul St. Mary's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT06058247
Collaborator
(none)
368
1
2
41
9

Study Details

Study Description

Brief Summary

Malnutrition in critically ill patients is a global concern due to its association with increased infectious complications, prolonged hospital stays, and higher morbidity rates. Patients who undergo abdominal surgery are particularly vulnerable due to alterations in gastrointestinal function and prolonged fasting. Despite the significance of proper nutrition, guidelines remain broad, and practical implementation is often inadequate.

The investigators aimed to assess the effects of strict nutritional provision, targeting an energy adequacy of 80% or more and a protein intake of at least 1.5 g/kg/day, on in-hospital and 60-day mortality.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Active nutritional supplementation
  • Dietary Supplement: Conventional nutritional supplementation
N/A

Detailed Description

During the acute phase of critical illness, patients experience metabolic and physiological changes that affects their nutrition status. One prominent feature is the activation of stress hormones and inflammatory mediators, which contribute to a negative nitrogen balance, increased gluconeogenesis, and accelerated muscle proteolysis. Among these patients, those who undergo abdominal surgery are particularly vulnerable to malnutrition as they experience alterations in the structural barrier of the gastrointestinal tract, impaired nutrient absorption, and prolonged fasting due to concerns such as the integrity of an anastomosis. Thus, appropriate nutritional therapy should be prioritized for critically ill patients following abdominal surgery, and it should include adequate nutritional support to preserve lean body mass and organ function.

Despite the importance of nutritional supply, the recommendations for protein or calorie intake vary according to different guidelines, and this is the same for surgical patients. Additionally, some patients experience a delay in initiating nutritional support, and several studies reported that only 39 - 63% of the intended energy and 45 - 55% of the prescribed protein are being administered to critically ill patients during the acute phase. Furthermore, recent randomized controlled trials reported conflicting results with current guidelines, with some suggesting that lower calorie or higher protein dose administrations did not significantly impact clinical outcomes and may even worsen the outcomes for certain patient groups. Thus, the optimal nutritional provision target during the acute phase of critical illness, particularly for surgical patients, remains controversial, and there is no standardized protocol.

In our previous study, the malnutrition status upon admission, indicated by a modified Nutrition Risk in the Critically Ill (mNUTRIC) score of 5 or higher, and low energy adequacy during intensive care unit (ICU) stay were identified as mortality predictors in critically ill patients following abdominal surgery. The investigators aimed to assess the effects of strict nutritional provision, targeting an energy adequacy of 80% or more and a protein intake of at least 1.5 g/kg/day, on in-hospital and 60-day mortality. Additionally, the investigators investigated the appropriate target for nutrition support in critically ill patients who undergo abdominal surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
368 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Reducing In-Hospital and 60-Day Mortality in Critically Ill Patients After Surgery With Strict Nutritional Supplementation: A Prospective, Single-Labeled, Randomized Controlled Trial
Actual Study Start Date :
Mar 1, 2019
Actual Primary Completion Date :
Aug 1, 2022
Actual Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active nutritional supplementation

The participants in active nutritional supplementation arm received nutritional support targeting specific protein (over 1.5 g/kg/day) and calorie intake (over 20 kcal/kg/day), with consultation from the nutritional support team and the initiation of nutritional supplementation on the same day as intensive care unit admission.

Dietary Supplement: Active nutritional supplementation
The participants in active nutritional supplementation arm received consultation from the nutritional support team (NST) upon ICU admission, and nutritional supplementation was initiated on the same day. NST is a multidisciplinary support team comprised of physicians, nurses, dietitians, and pharmacists, which assesses the nutritional status of patients, and provides recommendations for nutritional therapy. Targets in the participants in active nutritional supplementation arm were protein supplementation at over 1.5 g/kg/day, calorie provision at over 20 kcal/kg/day, and energy adequacy of at least 80%. Energy target was estimated by multiplying the resting energy expenditure using the Harris and Benedict equation by an activity factor of 1.3 and a stress factor of 1.1. Actual body weight was used as the body weight for patients with a percent of ideal body weight (PIBW) of less than 120%, while adjusted body weight was used for patients with a PIBW greater than or equal to 120%.

Experimental: Conventional nutritional supplementation

The participants in conventional nutritional supplementation arm underwent conventional nutrition management without specific protein or caloric targets.

Dietary Supplement: Conventional nutritional supplementation
The participants in conventional nutritional supplementation arm received conservative nutritional management without specific protein or caloric targets.

Outcome Measures

Primary Outcome Measures

  1. 60-day mortality rate [Participants were followed upto 60th day after surgery]

    Proportion of patients who died within 60 days after surgery among participants

Secondary Outcome Measures

  1. In-hospital mortality rate [Participants were followed upto 60th day after surgery]

    Proportion of patients who died during the hospitalization period

  2. Incidence of postoperative complications [Participants were followed upto 60th day after surgery]

    Proportion of patients who died within 60 days after surgery among participants

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients admitted after abdominal surgery to our institution's surgical ICU

  • They were enrolled regardless of the surgical method, either open, laparoscopy, or robotic.

Exclusion Criteria:
  • aged under 18 years

  • underwent surgery under local or regional anesthesia

  • pregnant

  • readmitted to the ICU

  • diagnosed with renal failure and receiving renal replacement therapy

  • lacked individual data necessary to calculate the mNUTRIC score measured at ICU admission

  • failed to provide informed consent, or with 'do-not-resuscitate' status.

  • the patient was discharged or expired within 48 hours of ICU admission

  • patients diagnosed with multiorgan failure, represented by a high Sequential Organ Failure Assessment (SOFA) score (≥9) upon ICU admission

Contacts and Locations

Locations

Site City State Country Postal Code
1 Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital Seoul Seocho-gu, Banpo-dong Banpodaero 222 Korea, Republic of 137-701

Sponsors and Collaborators

  • Seoul St. Mary's Hospital

Investigators

  • Study Director: Hye sung Kim, The Catholic University of Korea

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eun Young Kim, Professor, Seoul St. Mary's Hospital
ClinicalTrials.gov Identifier:
NCT06058247
Other Study ID Numbers:
  • NUMIS_02
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2023